Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway

European Journal of Immunology

Volumn 35, Issue 5, 2005, Pages 1482-1490

  Augello, Andrea ^a,b   Tasso, Roberta ^a,b   Negrini, Simone Maria ^c   Amateis, Andrea ^a,b   Indiveri, Francesco ^c   Cancedda, Ranieri ^a,b   Pennesi, Giuseppina ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Immunosuppression; Lymphocyte activation; Stem cells

Indexed keywords

CYTOKINE RECEPTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELL STIMULATION; HEMATOPOIETIC STEM CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE; TARGET CELL;

ANIMALS; ANTIGENS, CD; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; B-LYMPHOCYTES; BONE MARROW; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELLS; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 18844404360     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425405     Document Type: Article

References (32)

1. Caplan, A., Mesenchymal stem cells. J. Orthop. Res. 1991. 9: 641-650.
2. Bianco, P., Riminucci, M., Gronthos, S. and Robey, P., Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001. 19: 180-192.
3. Caplan, A., In vivo remodeling. Ann. N. Y Acad. Sci. 2002. 961: 307-308.
4. Quarto, R., Mastrogiacomo, M., Cancedda, R., Kutepov, S., Mukhachev, V., Lavroukov, A., Kon, E. and Marcacci, M., Repair of large bone defects with the use of autologous bone marrow stromal cells. N. Engl. J. Med. 2001. 344: 385-386.
5. Horwitz, E., Prockop, D., Fitzpatrick, L., Koo, W., Gordon, P., Neel, M., Sussman, M., Orchard, P., Marx, J., Pyeritz, R. and Brenner, M., Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 1999. 5: 309-313.
6. Ishida, T., Inaba, M., Hisha, H., Sugiura, K., Adachi, Y., Nagata, N., Ogawa, R., Good, R. and Ikehara, S., Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J. Immunol. 1994. 152: 3119-3127
7. Ikehara, S., Successful allogeneic bone marrow transplantation. Crucial roles of stromal cells in prevention of graft rejection. Acta Haematol 2001. 105: 172-178.
8. Maitra, B., Szekely, E., Gjini, K., Laughlin, M., Dennis, J., Haynesworth, S. and Koç1, O., Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T cell activation. Bone Marrow Transplant. 2004. 33: 597-604.
9. LeBlanc, K., Rasmusson, L, Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M. and Ringden, O., Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004. 363: 1439-1441.
10. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P., Matteucci, P., Grisanti, S. and Gianni, A., Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002. 99: 3838-3843.
11. Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E. and Dazzi, F., Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003. 101: 3722-3729.
12. Potian, J., Aviv, H., Ponzio, N., Harrison, J. and Rameshwar, P., Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J. Immunol. 2003. 171: 3426-3434.
13. Ozkaynak, E., Wang, L., Goodearl, A., McDonald, K., Qin, S., O'Keefe, T., Duoug, T., Smith, T., Gutierrez-Ramos, J., Rottman, J. et al., Programmed death-1 targeting can promote allograft survival. J. Immunol. 2002. 169: 6546-6553.
14. Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T., Tsuchiya, H., Pardoll, D., Okumura, K. et al., Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 2002. 169: 5538-5545.
15. Gao, W., Demirci, G., Strom, T. and Li, X., Stimulating PD-1 negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival. Transplantation 2003. 76: 994-999.
16. Freeman, G., Long, A., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L., Malenkovich, N., Okazaki, T., Byrne, M. et al., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 2000. 192: 1027-1034.
17. Latchman, Y., Wood, C., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A., Brown, J., Nunes, R. et al., PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2001. 2: 261-268.
18. Khaled, A. and Durum, S., Lymphocide: cytokines and the control of lymphoid homeostasis. Nat. Rev. Immunol. 2002. 2: 817-830.
19. McKarns, S., Schwartz, R. and Kaminski, N., Smad3 is essential for TGF-betal to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation. J. Immunol. 2004. 172: 4275-4284.
20. Groux, H. and Cottrez, F., The complex role of interleukin-10 in autoimmunity. J. Autoimmun. 2003. 20: 281-285.
21. Cooke, K. and Ferrara, J., A protective gene for graft-versus-host disease. N. Engl. J. Med. 2003. 349: 2183-2184.
22. Kuznetsov, S., Mankani, M., Gronthos, S., Satomura, K., Bianco, P. and Robey, P., Circulating skeletal stem cells. J. Cell Biol 2001. 153: 1133-1139.
23. Jiang, Y., Jahagirdar, B., Reinhardt, R., Schwartz, R., Keenek, C., Ortiz-Gonzalezk, X., Reyes, M., Lenvik, T., Lund, T., Blackstad, M. et al., Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002. 418: 41-49.
24. Peister, A., Mellad, J., Larson, B., Hall, B., Gibson, L. and Prockop, D., Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004. 103: 1662-1668.
25. Probst, H., McCoy, K., Okazaki, T., Honjo, T. and van den Broek, M., Resting dendritic cells induce peripheral CD8(+) T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 2005. 6: 280-286.
26. + T cell activation and cytolysis. Eur. J. Immunol. 2003. 33: 3117-3126.
27. Hori, J., Ng, T., Shatos, M., Klassen, H., Streilein, J. and Young, M., Neural progenitor cells lack immunogenicity and resist destruction as allografts. Stem Cells 2003. 21: 405-416.
28. Nelson, B., Martyak, T., Thompson, L., Moon, J. and Wang, T., Uncoupling of promitogenic and antiapoptotic functions of IL-2 by Smad-dependent TGF-beta signaling. J. Immunol. 2003. 170: 5563-5570.
29. + T cell homeostasis. J. Immunol. 2003. 170: 210-217.
30. + T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 2002. 196: 1335-1346.
31. + regulatory T cells generated ex vivo with IL-2 and TGF-β suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J. Immunol. 2004. 172: 1531-1539.
32. Aramaki, O., Shirasugi, N., Takayama, T., Shimazu, M., Kitajima, M., Ikeda, Y., Azuma, M., Okumura, K., Yagita, H. and Niimi, M., Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen. Transplantation 2004. 77: 6-12.